Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- Phase 2: single SC doses up to 40 mg; multiple doses in range 5–40 mg SC once weekly
- Phase 3 (STARS-021): weekly SC dose; exact dose arm not publicly confirmed in full